These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 8761307

  • 1. Autocrine hepatocyte growth factor/scatter factor-Met signaling induces transformation and the invasive/metastastic phenotype in C127 cells.
    Jeffers M, Rong S, Anver M, Vande Woude GF.
    Oncogene; 1996 Aug 15; 13(4):853-6. PubMed ID: 8761307
    [Abstract] [Full Text] [Related]

  • 2. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
    Li Y, Lal B, Kwon S, Fan X, Saldanha U, Reznik TE, Kuchner EB, Eberhart C, Laterra J, Abounader R.
    Cancer Res; 2005 Oct 15; 65(20):9355-62. PubMed ID: 16230398
    [Abstract] [Full Text] [Related]

  • 3. The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-met-urokinase plasminogen activator-plasmin proteolytic network.
    Webb CP, Hose CD, Koochekpour S, Jeffers M, Oskarsson M, Sausville E, Monks A, Vande Woude GF.
    Cancer Res; 2000 Jan 15; 60(2):342-9. PubMed ID: 10667586
    [Abstract] [Full Text] [Related]

  • 4. c-Met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype.
    Otsuka T, Takayama H, Sharp R, Celli G, LaRochelle WJ, Bottaro DP, Ellmore N, Vieira W, Owens JW, Anver M, Merlino G.
    Cancer Res; 1998 Nov 15; 58(22):5157-67. PubMed ID: 9823327
    [Abstract] [Full Text] [Related]

  • 5. Involvement of HGF/SF-Met signaling in prostate adenocarcinoma cells: evidence for alternative mechanisms leading to a metastatic phenotype in Pr-14c.
    MacDougall CA, Vargas M, Soares CR, Holzer RG, Ide AE, Jorcyk CL.
    Prostate; 2005 Jul 01; 64(2):139-48. PubMed ID: 15678502
    [Abstract] [Full Text] [Related]

  • 6. Requirement of Stat3 signaling for HGF/SF-Met mediated tumorigenesis.
    Zhang YW, Wang LM, Jove R, Vande Woude GF.
    Oncogene; 2002 Jan 10; 21(2):217-26. PubMed ID: 11803465
    [Abstract] [Full Text] [Related]

  • 7. Met and hepatocyte growth factor/scatter factor signal transduction in normal melanocytes and melanoma cells.
    Halaban R, Rubin JS, Funasaka Y, Cobb M, Boulton T, Faletto D, Rosen E, Chan A, Yoko K, White W.
    Oncogene; 1992 Nov 10; 7(11):2195-206. PubMed ID: 1331934
    [Abstract] [Full Text] [Related]

  • 8. Expression of the hepatocyte growth factor/scatter factor receptor tyrosine kinase is localized to epithelia in the adult mouse.
    Yang XM, Park M.
    Lab Invest; 1995 Oct 10; 73(4):483-91. PubMed ID: 7474919
    [Abstract] [Full Text] [Related]

  • 9. Hepatocyte growth factor stimulates cell motility in cultures of the striatal progenitor cells ST14A.
    Cacci E, Salani M, Anastasi S, Perroteau I, Poiana G, Biagioni S, Augusti-Tocco G.
    J Neurosci Res; 2003 Dec 01; 74(5):760-8. PubMed ID: 14635227
    [Abstract] [Full Text] [Related]

  • 10. HGF/SF-met signaling in the control of branching morphogenesis and invasion.
    Zhang YW, Vande Woude GF.
    J Cell Biochem; 2003 Feb 01; 88(2):408-17. PubMed ID: 12520544
    [Abstract] [Full Text] [Related]

  • 11. Hepatocyte growth factor/scatter factor induces feedback up-regulation of CD44v6 in melanoma cells through Egr-1.
    Recio JA, Merlino G.
    Cancer Res; 2003 Apr 01; 63(7):1576-82. PubMed ID: 12670907
    [Abstract] [Full Text] [Related]

  • 12. Dominant negative Met reduces tumorigenicity-metastasis and increases tubule formation in mammary cells.
    Firon M, Shaharabany M, Altstock RT, Horev J, Abramovici A, Resau JH, Vande Woude GF, Tsarfaty I.
    Oncogene; 2000 May 11; 19(20):2386-97. PubMed ID: 10828880
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of junction assembly in cultured epithelial cells by hepatocyte growth factor/scatter factor is concomitant with increased stability and altered phosphorylation of the soluble junctional molecules.
    Pasdar M, Li Z, Marreli M, Nguyen BT, Park M, Wong K.
    Cell Growth Differ; 1997 Apr 11; 8(4):451-62. PubMed ID: 9101091
    [Abstract] [Full Text] [Related]

  • 14. Constitutive c-Met signaling through a nonautocrine mechanism promotes metastasis in a transgenic transplantation model.
    Yu Y, Merlino G.
    Cancer Res; 2002 May 15; 62(10):2951-6. PubMed ID: 12019177
    [Abstract] [Full Text] [Related]

  • 15. Receptor chimeras indicate that the met tyrosine kinase mediates the motility and morphogenic responses of hepatocyte growth/scatter factor.
    Zhu H, Naujokas MA, Park M.
    Cell Growth Differ; 1994 Apr 15; 5(4):359-66. PubMed ID: 8043510
    [Abstract] [Full Text] [Related]

  • 16. Met expression and sarcoma tumorigenicity.
    Rong S, Jeffers M, Resau JH, Tsarfaty I, Oskarsson M, Vande Woude GF.
    Cancer Res; 1993 Nov 15; 53(22):5355-60. PubMed ID: 7693339
    [Abstract] [Full Text] [Related]

  • 17. Multiple aspects of the phenotype of mammary epithelial cells transformed by expression of activated M-Ras depend on an autocrine mechanism mediated by hepatocyte growth factor/scatter factor.
    Zhang KX, Ward KR, Schrader JW.
    Mol Cancer Res; 2004 Apr 15; 2(4):242-55. PubMed ID: 15140946
    [Abstract] [Full Text] [Related]

  • 18. Hepatocyte growth factor/scatter factor (HGF/SF), the c-met receptor and the behaviour of epithelial cells.
    Gherardi E, Sharpe M, Lane K, Sirulnik A, Stoker M.
    Symp Soc Exp Biol; 1993 Apr 15; 47():163-81. PubMed ID: 8165564
    [Abstract] [Full Text] [Related]

  • 19. A novel recombinant soluble splice variant of Met is a potent antagonist of the hepatocyte growth factor/scatter factor-Met pathway.
    Tiran Z, Oren A, Hermesh C, Rotman G, Levine Z, Amitai H, Handelsman T, Beiman M, Chen A, Landesman-Milo D, Dassa L, Peres Y, Koifman C, Glezer S, Vidal-Finkelstein R, Bahat K, Pergam T, Israel C, Horev J, Tsarfaty I, Ayalon-Soffer M.
    Clin Cancer Res; 2008 Jul 15; 14(14):4612-21. PubMed ID: 18628476
    [Abstract] [Full Text] [Related]

  • 20. Identification of a hepatocyte growth factor autocrine loop in a murine mammary carcinoma.
    Rahimi N, Tremblay E, McAdam L, Park M, Schwall R, Elliott B.
    Cell Growth Differ; 1996 Feb 15; 7(2):263-70. PubMed ID: 8822210
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.